Optimising Gene Editing Delivery Technologies to Achieve Precise Targeting, Enhance Manufacturability & Accelerate Clinical Translation
- Address manufacturing and CMC challenges for ligand-directed and next-gen formulations
- Review a nanomedicine platform for production and application in therapy
- Gain insights from case studies on tissue-specific delivery in rare diseases, cancer and CNS diseases